VNRX

VolitionRX Limited

0.79 USD
+0.02 (+2.60%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

VolitionRX Limited stock is up 27.42% since 30 days ago. The next earnings date is Aug 12, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 38.46% of the previous 12 May’s closed higher than April. 100% of analysts rate it a buy.

About VolitionRX Limited

VolitionRx Limited engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; NuQ Nets, monitoring the immune system, and NuQ Vet cancer screening test for veterinary applications. The company operates Nucleosomics a technology platform.

  • Cantor Fitzgerald
    Thu May 16, 11:09
    buy
    confirm
  • EF Hutton
    Tue May 14, 13:08
    buy
    confirm